Champalimaud Foundation
Hospitals and Health CareLisbon, Portugal501-1000 Employees
Located in Lisboa, Portugal, the Champalimaud Foundation operates in the hospitals and health care sector as a research-driven institution. It runs programs for advanced biomedical research and provides clinical care of the highest standard, aiming to translate scientific discoveries into solutions that improve quality of life worldwide. The organization emphasizes independence, rigorous inquiry, dedication, creativity, and the highest ethical and scientific standards as it pursues leadership in scientific and technological innovation to prevent, diagnose, and treat disease. Its primary beneficiaries include patients who receive clinical care and researchers who collaborate within its biomedical programs. Recent developments illustrate its external collaborations and strategic acquisitions, including a partnership with Delta Cafés to study potential breast cancer benefits of coffee consumption. The foundation also announced the acquisition of a portfolio of T-cell receptor programs and related assets from Medigene Immunotherapies, together with an exclusive license with Helmholtz Munich for chimeric co-stimulatory receptor technologies.
1-888-653-2347 
support@leadiq.com 
